miRview mets

Home > miRview mets: Healthcare Professional > miRview mets

miRview™ squamous

miRview™ meso

The next generation of
cancer diagnostics is here

Rosetta Genomics is pleased to introduce
the next generation of cancer diagnostics: microRNA assays.

Introducing miRview™ mets

miRview™ mets is the first microRNA-based molecular diagnostic test designed to identify the origin of metastatic tumors, designed with Cancer of Unknown Primary (CUP) patients in mind . The test offers:

Accuracy
Efficiency
Simple interpretation
Routine sample preparation

Download Brochure
	For additional information, please download brochure Download